EU anti-trust probe maintained on Johnson & Johnson, Novartis

January 31, 2013

European anti-trust authorities said Thursday they had sent written objections to pharamaceutical giants Johnson & Johnson and Novartis over a deal affecting generic medicine.

The European Commission said it had informed the US and Swiss companies of "objections regarding an concluded between their respective Dutch subsidiaries on fentanyl, a strong pain-killer."

The sending of a so-called "statement of objections" effectively means that a probe opened by the Commission in October 2011 was continuing.

The EU, which polices a single market of half a billion consumers, said it believed that an agreeement between the two drugs giants "delayed the market entry of a cheaper generic medicine in the Netherlands."

A statement said: "If our preliminary conclusions are confirmed, the Dutch subsidiaries of Johnson & Johnson and Novartis entered into a so-called 'co-promotion' agreement to avoid competing against each other, depriving users of fentanyl in the Netherlands from access to a cheaper pain killer."

Commpetition Commissioner Joaquin Almunia said that Brussels would continue to fight undue delays in the market entry of generic medicines so that European citizens have access to affordable healthcare.

"It is also important to make sure that pharmaceutical companies do not free ride our welfare state and health insurance systems, especially in this period of constraints on public spending", Almunia added.

The EU executive said Janssen-Cilag, the J&J subsidiary supplying fentanyl in the Netherlands, concluded a so-called "co-promotion agreement" with its close generic competitor Sandoz, a Novartis subsidiary, in July 2005.

The agreement foresaw monthly payments from Janssen-Cilag to Sandoz for as long as no generic product was launched in the Dutch market.

Consequently, Sandoz abstained from entering the market with generic fentanyl patches for the duration of the agreement from July 2005 until December 2006.

Fentanyl is a pain-killer stronger than morphine that is used to treat patients with severe pain.

"This may have delayed the entry of a cheaper generic medicine for seventeen months and kept prices for fentanyl in the Netherlands artificially high," the Commission statement said.

A Commission spokesman refused to state the size of the monthly payments to Sandoz.

The probe is a further step in the Commission's fight against undue delay to generic entry though the sending of a statement of objections does not prejudge the final outcome.

Explore further: EU says to set out anti-trust case against Samsung soon

Related Stories

EU says to set out anti-trust case against Samsung soon

December 20, 2012
The EU will set out its case against Samsung Electronics "very soon" following an anti-trust probe of the smartphone and mobile tablet market, Competition Commissioner Joaquin Almunia said Thursday.

Australian pain-killer switch affects hundreds

October 16, 2012
Hundreds of Australians were given water instead of pain-killing medication after thieves siphoned off the drugs from ambulance supplies and refilled the empty vials from the tap, officials said Tuesday.

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.